谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Supplemental Figure 2 from Long-term Follow-up of Treatment with Ibrutinib and Rituximab in Patients with High-Risk Chronic Lymphocytic Leukemia

Preetesh Jain,Michael J. Keating, William G. Wierda,Mariela Sivina,Philip A. Thompson,Alessandra Ferrajoli,Zeev Estrov,Hagop Kantarjian, Susan O'Brien,Jan A. Burger

crossref（2023）

引用 0|浏览1
暂无评分
摘要
Changes in hematologic parameters on treatment with ibrutinib and rituximab up to 3 years.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要